価格表
在庫・価格 : 2025年04月27日 05時50分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Flt-1, Soluble, Human, ELISA Kit, Quantikine, 2nd Generation (96 well) <VEGF Receptor1, ELISA Kit> データシート※最新のデータシートでない場合があります |
DVR100B |
RSDアールアンドディー システムズ R&D Systems, Inc. |
1 kit | 本製品は製品内容等が変更されました 変更先製品 | 追加 |
在庫・価格 : 2025年04月27日 05時50分 現在
Flt-1, Soluble, Human, ELISA Kit, Quantikine, 2nd Generation (96 well) <VEGF Receptor1, ELISA Kit>
使用文献
- No.: 1
-
文献情報:
Eubank TD et al. GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity 2004 Dec;21(6):831-42
Eubank TD et al
2004/01/01
-
備考:
Sample Type: Cell Supernates -
参照:
- No.: 2
-
文献情報:
Levine RJ et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005 Jan;293(1):77-85
Levine RJ et al
2005/01/01
-
備考:
Species: Human, Sample type: Urine -
参照:
- No.: 3
-
文献情報:
Li H et al. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta ;26(2-3):210-7
Li H et al
-
備考:
Species: Human, Sample type: Cell Supernates -
参照:
- No.: 4
-
文献情報:
Zhang Z et al. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1. Mol. Ther. 2005 Apr;11(4):553-62
Zhang Z et al
2005/01/01
-
備考:
Sample Type: Cell Supernates,Homogenized Tissue - Protocol Included -
参照:
- No.: 5
-
文献情報:
Tseng JJ et al. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta 2006 Jan;27(1):70-8
Tseng JJ et al
2006/01/01
-
備考:
human placenta -
参照:
- No.: 6
-
文献情報:
Masuyama H et al. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am. J. Obstet. Gynecol. 2006 Feb;194(2):551-6
Masuyama H et al
2006/01/01
-
備考:
human serum -
参照:
- No.: 7
-
文献情報:
Levine RJ et al. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am. J. Obstet. Gynecol. 2006 Apr;194(4):1034-41
Levine RJ et al
2006/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 8
-
文献情報:
Harding TC et al. AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma. Mol. Ther. 2006 May;13(5):956-66
Harding TC et al
2006/01/01
-
備考:
human transfected cells -
参照:
- No.: 9
-
文献情報:
Itoh H et al. Hypoxia regulates vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 secretion by human oviductal epithelial cells and stromal fibroblasts. Fertil. Steril. 2006 Apr;85 Suppl 1:1097-102
Itoh H et al
2006/01/01
-
備考:
human oviduct epithelial cells (OEC) and oviductal stromal fibroblasts (OSF) -
参照:
- No.: 10
-
文献情報:
Caine GJ et al. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. Cancer Lett. 2007 Apr;248(1):131-6
Caine GJ et al
2007/01/01
-
備考:
Sample Type: Plasma (Citrate) -
参照:
- No.: 11
-
文献情報:
Asimakopoulos B et al. Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures. Fertil. Steril. 2006 Sep;86(
Asimakopoulos B et al
2006/01/01
-
備考:
Species: Human, Application: Cell Supernates -
参照:
- No.: 12
-
文献情報:
Wallner W et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin. Sci. 2007 Jan;112(1):51-7
Wallner W et al
2007/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 13
-
文献情報:
Levine RJ et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 2006 Sep;355(10):992-1005
Levine RJ et al
2006/01/01
-
備考:
human serum -
参照:
- No.: 14
-
文献情報:
Boulanger E et al. Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation. Kidney Int. 2007 Jan;71(2):126-33
Boulanger E et al
2007/01/01
-
備考:
Sample Type: Cell Supernates -
参照:
- No.: 15
-
文献情報:
Caine GJ et al. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients. Cancer Lett. 2007 Jun;251(2):296-301
Caine GJ et al
2007/01/01
-
備考:
Species: Human, Sample type: Plasma (Citrate) -
参照:
- No.: 16
-
文献情報:
Lockwood CJ et al. Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia. Am. J. Pathol. 2007 Apr;170(4):1398-405
Lockwood CJ et al
2007/01/01
-
備考:
Sample Type: Cell Supernates -
参照:
- No.: 17
-
文献情報:
Clavel G et al. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin. Immunol. 2007 Aug;124(2):158-64
Clavel G et al
2007/01/01
-
備考:
Species: Human, Sample type: Serum -
参照:
- No.: 18
-
文献情報:
Brownbill P et al. Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule. Endocrinology 2007 Oct;148(10):4734-44
Brownbill P et al
2007/01/01
-
備考:
Species: Human, Sample type: Serum -
参照:
- No.: 19
-
文献情報:
Gutman G et al. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertil. Steril. 2008 Apr;89(4):922-6
Gutman G et al
2008/01/01
-
備考:
Species: Human, Application: Follicular Fluid, Serum -
参照:
- No.: 20
-
文献情報:
Kanasaki K et al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008 Jun;453(7198):1117-21
Kanasaki K et al
2008/01/01
-
備考:
Species: Human, Application: Cell Supernates -
参照:
- No.: 21
-
文献情報:
Sela S et al. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ. Res. 2008 Jun;102(12):1566-74
Sela S et al
2008/01/01
-
備考:
Species: Human, Application: Cell Supernates -
参照:
- No.: 22
-
文献情報:
Jeyabalan A et al. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am. J. Hypertens. 2008 Aug;21(8):943-7
Jeyabalan A et al
2008/01/01
-
備考:
Species: Human, Application: Plasma (EDTA) -
参照:
- No.: 23
-
文献情報:
Findley CM et al. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J. Am. Coll. Cardiol. 2008 Jul;52(5):387-93
Findley CM et al
2008/01/01
-
備考:
Species: Human, Application: Plasma (EDTA) -
参照:
- No.: 24
-
文献情報:
Muehlenbachs A et al. Natural selection of FLT1 alleles and their association with malaria resistance in utero. Proc. Natl. Acad. Sci. U.S.A. 2008 Sep;105(38):14488-91
Muehlenbachs A et al
2008/01/01
-
備考:
Species: Human, Application: Cell Supernate -
参照:
- No.: 25
-
文献情報:
Brownbill P et al. Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia. Placenta 2008 Nov;29(11):950-5
Brownbill P et al
2008/01/01
-
備考:
Sample Type: Serum,other: venous perfusate -
参照:
- No.: 26
-
文献情報:
Rajakumar A et al. Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. Placenta 2009 Jan;30(1):25-34
Rajakumar A et al
2009/01/01
-
備考:
Sample Type: Whole Tissue Supernate -
参照:
- No.: 27
-
文献情報:
Sallinen H et al. Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice. Mol. Ther. 2009 Feb;17(2):278-84
Sallinen H et al
2009/01/01
-
備考:
Sample Type: Plasma (Not Specified) -
参照:
- No.: 28
-
文献情報:
Heydarian M et al. Novel splice variants of sFlt1 are upregulated in preeclampsia. Placenta 2009 Mar;30(3):250-5
Heydarian M et al
2009/01/01
-
備考:
Sample Type: Cell Supernates,Serum -
参照:
- No.: 29
-
文献情報:
Sandhofer A et al. Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis 2009 Sep;206(1):265-9
Sandhofer A et al
2009/01/01
-
備考:
Sample Type: Plasma (Not Specified) -
参照:
- No.: 30
-
文献情報:
Bourlev V et al. Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil. Steril. 2010 Jun;94(1):52-7
Bourlev V et al
2010/01/01
-
備考:
Sample Type: Peritoneal Fluid,Serum -
参照:
- No.: 31
-
文献情報:
Verlohren S et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am. J. Obstet. Gynecol. 2010 Feb;202(2):161.e1-161.e11
Verlohren S et al
2010/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 32
-
文献情報:
Levine RJ et al. Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ 2009;339:b4336
Levine RJ et al
2009/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 33
-
文献情報:
Kosugi T et al. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice. Am. J. Physiol. Renal Physiol. 2010 Mar;298(3):F609-16
Kosugi T et al
2010/01/01
-
備考:
Sample Type: Serum,Urine -
参照:
- No.: 34
-
文献情報:
Brookes K et al. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. Br. J. Cancer 2010 May;102(10):1524-32
Brookes K et al
2010/01/01
-
備考:
Sample Type: Plasma (EDTA) -
参照:
- No.: 35
-
文献情報:
Powers RW et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS ONE 2010;5(10):e13263
Powers RW et al
2010/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 36
-
文献情報:
Jeyabalan A et al. Effect of smoking on circulating angiogenic factors in high risk pregnancies. PLoS ONE 2010;5(10):e13270
Jeyabalan A et al
2010/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 37
-
文献情報:
Rahbari NN et al. Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer. BMC Cancer 2011;11:286
Rahbari NN et al
2011/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 38
-
文献情報:
Landt S et al. Prognostic significance of angiogenic factors in uterine cervical cancer. Anticancer Res. 2011 Aug;31(8):2589-95
Landt S et al
2011/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 39
-
文献情報:
Landt S et al. In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancer. Anticancer Res. 2011 Aug;31(8):2609-15
Landt S et al
2011/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 40
-
文献情報:
Jeevaratnam K et al. Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study. BMC Pregnancy Childbirth 2010;10:58
Jeevaratnam K et al
2010/01/01
-
備考:
Sample Type: Plasma (Not Specified) -
参照:
- No.: 41
-
文献情報:
Dubois SG et al. Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin. Cancer Res. 2011 Aug;17(15):5113-22
Dubois SG et al
2011/01/01
-
備考:
Sample Type: Plasma (Not Specified) -
参照:
- No.: 42
-
文献情報:
Patten IS et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012 May;485(7398):333-8
Patten IS et al
2012/01/01
-
備考:
Sample Type: Plasma -
参照:
- No.: 43
-
文献情報:
Huang QT et al. Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia. Placenta 2013 Oct;34(10):949-52
Huang QT et al
2013/01/01
-
備考:
Sample Type: Cell Culture Supernates -
参照:
- No.: 44
-
文献情報:
El-Tarhouny SA et al. Placental growth factor and soluble Fms-like tyrosine kinase 1 in diabetic pregnancy: A possible relation to distal villous immaturity. Histol. Histopathol. 2014 Feb;29(2):259-72
El-Tarhouny SA et al
2014/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 45
-
文献情報:
Liu LY et al. Integrating multiple 'omics' analyses identifies serological protein biomarkers for preeclampsia. BMC Med 2013;11:236
Liu LY et al
2013/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 46
-
文献情報:
Necchi A et al. Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy. Br. J. Cancer 2014 Jan;110(1):26-33
Necchi A et al
2014/01/01
-
備考:
Sample Type: Plasma -
参照:
- No.: 47
-
文献情報:
White WM et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS ONE 2014;9(3):e92693
White WM et al
2014/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 48
-
文献情報:
Sallinen H et al. Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer. BMC Cancer 2014;14:696
Sallinen H et al
2014/01/01
-
備考:
Sample Type: Serum -
参照:
- No.: 49
-
文献情報:
Bessho H et al. Inhibition of placental growth factor in renal cell carcinoma. Anticancer Res. 2015 Jan;35(1):531-41
Bessho H et al
2015/01/01
-
備考:
Sample Type: Cell Culture Supernates,Plasma -
参照: